Genome-wide rationally-designed mutations leading to enhanced lysine production in E. coli
US11078458B2 · kind B2 · utility
0Cited by
66References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 26, 2021 |
| Grant date | Aug 3, 2021 |
| Priority date | — |
| Expiry date | Jan 26, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12R2001/19
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure relates to various different types of variants in E. coli coding and noncoding regions leading to enhanced lysine production for, e.g., supplements and nutraceuticals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.